---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-053553"
form_type: "8-K"
ticker: "RXST"
cik: "0001111485"
company_name: "RxSight, Inc."
filed_at: "2024-05-06T23:59:59+00:00"
generated_at: "2026-06-02T21:42:35.584987+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# RxSight Q1 revenue $29.5M (+69% YoY), raises FY2024 guidance

## Summary
- LAL volume up 92% to 20,218 units; LDD installed base reaches 732 (+61% YoY).
- Gross margin expands to 70% from 59% on favorable mix and lower production costs.
- Net loss narrows to $9.1M ($0.25/share) from $13.2M ($0.42); adjusted loss $4.4M ($0.12).
- Raises FY2024 revenue guidance to $132-137M (from $128-135M) and gross margin to 68-70%.
- Cash remains strong at $125.4M, down slightly from $127.2M at year-end.

## SEC filing metadata
- accession: 0000950170-24-053553
- form_type: 8-K
- ticker: RXST
- cik: 0001111485
- company_name: RxSight, Inc.
- filed_at: 2024-05-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1111485/000095017024053553/0000950170-24-053553-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1111485/000095017024053553/rxst-20240506.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-053553
- JSON: https://secwatch.observer/filing/0000950170-24-053553.json
- Plain text: https://secwatch.observer/filing/0000950170-24-053553.txt

## Key facts
- Earnings Releases
  RxSight, Inc. reported the three months ended March 31, 2024 results: revenue $29.5 million, net income $(9.1) million, EPS $(0.25) per basic and diluted share. Guidance raised.
  - Period: the three months ended March 31, 2024
  - Revenue: $29.5 million
  - Net income: $(9.1) million
  - EPS: $(0.25) per basic and diluted share
  - Guidance: raised
  - Result: reported results
  source text: following cataract surgery, today reported financial results for the three months ended March 31, 2024. Key Quarterly Highlights • Reported first quarter 2024 revenue of $29.5 million, an increase of 69% compared to the first quarter of 2023, reflecting: • The sale of 20,218 Light Adjustable Lenses (LAL®/LAL+TM), representing a 92% increase in procedure volume
  evidence_url: https://www.sec.gov/Archives/edgar/data/1111485/000095017024053553/0000950170-24-053553-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.